ABSTRACT
Bone marrow (BM) tissue biopsy evaluation, including trephine biopsy and clot section, is an integral part of BM investigation and is often followed by ancillary studies, in particular immunohistochemistry (IHC). IHC provides in situ coupling of morphological assessment and immunophenotype. The number of different IHC tests that can be applied to BM trephine biopsies and the number of indications for IHC testing is increasing concurrently with the development of flow cytometry and molecular diagnostic methods. An international Working Party for the Standardization of Bone Marrow IHC was formed by the International Council for Standardization in Hematology (ICSH) to prepare a set of guidelines for the standardization of BM IHC based on currently available published evidence and modern understanding of quality assurance principles as applied to IHC in general. The guidelines were discussed at the ICSH General Assemblies and reviewed by an international panel of experts to achieve further consensus and represent further development of the previously published ICSH guidelines for the standardization of BM specimens handling and reports.
Subject(s)
Bone Marrow Examination/standards , Bone Marrow/pathology , Flow Cytometry/standards , Immunohistochemistry/standards , Immunophenotyping/standards , Biopsy/standards , Bone Marrow/surgery , Decalcification Technique/standards , Humans , International Cooperation , Laboratory Proficiency Testing , Paraffin Embedding/standards , Quality Control , Tissue Fixation/standardsABSTRACT
Splenic hamartoma is a rare tumor-like lesion composed of structurally disorganized red pulp elements. It has been hypothesized that two other splenic lesions, cord capillary hemangioma and myoid angioendothelioma, may fall within the spectrum of splenic hamartoma, simply representing morphological variants. In this study, we compared the vascular and stromal composition of cord capillary hemangioma and myoid angioendothelioma with those of classical hamartoma. In addition, we assessed the clonal vs polyclonal nature of the lesions in nine female cases by performing clonality analysis for X-chromosome inactivation at the human androgen receptor locus (HUMARA) on laser-assisted microdissected samples. In 15 of 17 cases, increased reticulin and/or collagen content was observed. The classical hamartoma cases showed a vasculature predominantly composed of CD8+ CD31+ CD34- splenic sinuses, whereas cases of cord capillary hemangioma and myoid angioendothelioma contained many CD8- CD31+ CD34+ cord capillaries, but very little CD8+ vasculature. All cases lacked expression of D2-40 and Epstein Barr virus-encoded RNA. All cases showed a proliferation index of ≤5% by Ki-67. Cases of classical hamartoma lacked significant perisinusoidal expression of collagen IV and low-affinity nerve growth factor receptor. Both markers were variably expressed in the other lesions. Increased CD163-positive histiocytes were found in four cases (three cord capillary hemangiomas and one myoid angioendothelioma). HUMARA analysis was informative in all nine tested cases, of which three cases showed a non-random X-chromosome inactivation pattern, indicating clonality. All three clonal cases were cord capillary hemangiomas. Our study has shown that in spite of considerable morphologic heterogeneity and overlapping features, classical hamartoma and cord capillary hemangioma and myoid angioendothelioma are different in terms of their vascular and stromal composition. Clonality analysis supports a true neoplastic origin for the cord capillary hemangioma. A larger study using additional immunohistochemical and molecular studies is necessary to further evaluate the biological significance of the current findings.
Subject(s)
Chromosomes, Human, X , Hamartoma/genetics , Hemangioma, Capillary/genetics , Splenic Neoplasms/genetics , X Chromosome Inactivation/genetics , Adolescent , Adult , Aged , Child , Clone Cells , Diagnosis, Differential , Female , Hamartoma/pathology , Hemangioendothelioma/genetics , Hemangioendothelioma/pathology , Hemangioma, Capillary/pathology , Humans , Male , Middle Aged , Splenic Neoplasms/pathology , Young AdultABSTRACT
BACKGROUND AND AIMS: In diagnostic immunohistochemistry (IHC), daily quality control/quality assurance measures (QC/QA) and participation in external quality assurance programmes (EQA) are important in ensuring good laboratory practice and patient care. Bone marrow trephine biopsies (BMTB) have been generally excluded from EQA programmes for diagnostic IHC due to a lack of standards for tissue processing. The European Bone Marrow Working Group (EBMWG) has set up an EBMWG IHC Committee with the task of exploring the plausibility of an EQA programme for BMTB IHC in Europe. METHODS: 28 laboratories participated in a web-based anonymous survey; 19 laboratories submitted a total of 109 slides stained for CD34, CD117, CD20, CD3, Ki-67 and a megakaryocyte marker of choice. RESULTS: Eight different fixatives and nine different decalcification methods were used. While 93% of participants believed that they produced excellent results in BMTB IHC, only 4/19 (21%) laboratories did not have any poor results. CD117 and Ki-67, with 53% and 50% poor results, respectively, were the most problematic immunostains, while CD20 was the least problematic, with only 11% poor results. CONCLUSIONS: The EBMWG IHC Committee calls for a reduction in the tissue processing methods for BMTB and establishment of an EQA programme for BMTB IHC to help diagnostic IHC laboratories calibrate their tests according to expert recommendations. This is especially necessary in the light of recent introduction of predictive IHC tests in BMTB.
Subject(s)
Bone Marrow Examination/standards , Hematologic Diseases/pathology , Hematology/standards , Immunohistochemistry/standards , Laboratories/standards , Quality Control , Antigens, CD20/analysis , Antigens, CD34/analysis , Bone Marrow Examination/methods , CD3 Complex/analysis , Europe , Humans , Ki-67 Antigen/analysis , Megakaryocytes/pathology , Pilot Projects , Proto-Oncogene Proteins c-kit/analysisABSTRACT
AIMS: Kaposi sarcoma herpesvirus (KSHV) is aetiologically related to Kaposi sarcoma, classical and extracavitary primary effusion lymphoma (PEL; EC-PEL) and multicentric Castleman disease (MCD), entities preferentially occurring in HIV-infected individuals. Characterization of HIV-associated PELs/EC-PELs suggests that the KSHV-infected malignant cells originate from a pre-terminal stage of B-cell differentiation. However, only limited phenotypic studies have been performed on HIV+ MCD, including for PR domain containing 1 with zinc finger domain/B lymphocyte-induced maturation protein 1 (PRDM1/BLIMP1), a key regulator of terminal B-cell differentiation. The aim was to characterize KSHV-infected cells in 17 cases of HIV+ MCD. METHODS AND RESULTS: Double immunohistochemistry and immunohistochemistry-in situ hybridization were used to characterize the KSHV-infected cells in MCD; the results were compared with the phenotypic profiles of 39 PELs/EC-PELs and seven PEL cell lines. Whereas the immunophenotype of KSHV-infected cells in MCD and malignant KSHV+ PEL cells was similar (PAX5, Bcl-6-; PRDM1/BLIMP1, IRF4/MUM1+; Ki67+), the MCD KSHV-infected cells differed, as they expressed OCT2, cytoplasmic lambda immunoglobulin; variably expressed CD27; lacked CD138; and were Epstein-Barr virus negative. CONCLUSIONS: Although both PEL and MCD originate from KSHV-infected pre-terminally differentiated B cells, these findings, with previously reported genetic studies, indicate HIV+ MCD may arise from extrafollicular B cells, whereas PELs may originate from cells that have traversed the germinal centre.
Subject(s)
B-Lymphocytes/virology , Castleman Disease/virology , HIV Infections/complications , Herpesviridae Infections/virology , Herpesvirus 8, Human , Lymphoma, Primary Effusion/virology , Adult , B-Lymphocytes/metabolism , Castleman Disease/immunology , Castleman Disease/metabolism , Cell Differentiation , Female , Herpesvirus 8, Human/immunology , Herpesvirus 8, Human/metabolism , Humans , Immunohistochemistry , Immunophenotyping , In Situ Hybridization , Lymphoma, Primary Effusion/immunology , Male , Middle AgedABSTRACT
The organization and expression of the BCL-6 gene in normal and neoplastic thymic T cells has not been fully determined. We examined 8 precursor T-cell lymphoblastic lymphomas (T-LBLs) and found significant BCL-6 expression in 4 cases. Three of the BCL-6(+) cases expressed a common thymocyte phenotype (CD4(+), CD8(+)), and one expressed a precursor thymocyte phenotype (CD4(-), CD8(-)). In 6 cases evaluated, including those expressing BCL-6, molecular analyses demonstrated a germline configuration of the BCL-6 gene and a wild-type BCL-6 gene first exon-intron boundary region. We also evaluated 12 normal prenatal and postnatal thymuses for BCL-6 protein. BCL-6 was expressed by most cortical thymocytes and by scattered medullary thymocytes. BCL-6(+) cortical and medullary thymocytes also expressed CD2, CD3, CD4, CD5, CD7, or CD8. We further analyzed the pattern of BCL-2 and BCL-X(L) expression and their coexpression with BCL-6 in normal thymus and T-LBL and compared it to that of follicle centers of reactive lymph nodes and follicular lymphoma. BCL-6(+) cortical thymocytes coexpressed BCL-X(L) but not BCL-2. All 4 BCL-6(+) T-LBLs and 4 BCL-6(-) T-LBLs coexpressed BCL-2 and BCL-X(L). Conceivably, T-LBLs may arise through clonal expansion of cortical thymocytes normally expressing the BCL-6 protein. The pattern of BCL-6, BCL-2, and BCL-X(L) expression in cortical thymocytes is highly reminiscent of germinal centers, and the abnormal coexpression of BCL-2, BCL-X(L), and BCL-6 in T-LBL is analogous to coexpression in follicle center cell lymphomas, suggesting that coexpression of these anti-apoptotic genes may contribute to the pathogenesis of T-LBL.
Subject(s)
DNA-Binding Proteins/metabolism , Proto-Oncogene Proteins/metabolism , Thymus Gland/embryology , Transcription Factors/metabolism , Adolescent , Adult , Apoptosis/drug effects , Child , Child, Preschool , Female , Fetus/chemistry , Fetus/cytology , Humans , Immunophenotyping , Infant , Infant, Newborn , Lymphoma, Follicular/etiology , Lymphoma, Follicular/metabolism , Lymphoma, T-Cell/etiology , Lymphoma, T-Cell/metabolism , Lymphoma, T-Cell/pathology , Male , Middle Aged , Precursor Cell Lymphoblastic Leukemia-Lymphoma/etiology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/metabolism , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Proto-Oncogene Proteins c-bcl-2/metabolism , Proto-Oncogene Proteins c-bcl-6 , Thymus Gland/chemistry , Thymus Gland/pathology , bcl-X ProteinABSTRACT
Emerging data suggest that VEGF receptors are expressed by endothelial cells as well as hematopoietic stem cells. Therefore, we hypothesized that functional VEGF receptors may also be expressed in malignant counterparts of hematopoietic stem cells such as leukemias. We demonstrate that certain leukemias not only produce VEGF but also express functional VEGFR-2 in vivo and in vitro, resulting in the generation of an autocrine loop that may support leukemic cell survival and proliferation. Approximately 50% of freshly isolated leukemias expressed mRNA and protein for VEGFR-2. VEGF(165) induced phosphorylation of VEGFR-2 and increased proliferation of leukemic cells, demonstrating these receptors were functional. VEGF(165) also induced the expression of MMP-9 by leukemic cells and promoted their migration through reconstituted basement membrane. The neutralizing mAb IMC-1C11, specific to human VEGFR-2, inhibited leukemic cell survival in vitro and blocked VEGF(165)-mediated proliferation of leukemic cells and VEGF-induced leukemic cell migration. Xenotransplantation of primary leukemias and leukemic cell lines into immunocompromised nonobese diabetic mice resulted in significant elevation of human, but not murine, VEGF in plasma and death of inoculated mice within 3 weeks. Injection of IMC-1C11 inhibited proliferation of xenotransplanted human leukemias and significantly increased the survival of inoculated mice. Interruption of signaling by VEGFRs, particularly VEGFR-2, may provide a novel strategy for inhibiting leukemic cell proliferation.
Subject(s)
Leukemia/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Receptors, Growth Factor/metabolism , Animals , Antibodies, Monoclonal/pharmacology , Base Sequence , Cell Division/physiology , Cell Movement/drug effects , Cell Movement/physiology , DNA Primers/genetics , Endothelial Growth Factors/genetics , Endothelial Growth Factors/metabolism , Endothelial Growth Factors/pharmacology , Gene Expression , Graft Survival , Humans , Leukemia/genetics , Leukemia/pathology , Lymphokines/genetics , Lymphokines/metabolism , Lymphokines/pharmacology , Matrix Metalloproteinase 9/biosynthesis , Mice , Mice, Inbred NOD , Neoplasm Transplantation , Neoplastic Cells, Circulating , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Neoplasm/genetics , RNA, Neoplasm/metabolism , Receptor Protein-Tyrosine Kinases/genetics , Receptors, Growth Factor/genetics , Receptors, Vascular Endothelial Growth Factor , Signal Transduction , Transplantation, Heterologous , Tumor Cells, Cultured , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth FactorsABSTRACT
Histopathological identification of invasive breast carcinoma in its earliest phases is fraught with pitfalls. Preinvasive malignant lesions complicated by radial scar, sclerosing adenosis, and lobular cancerization, among other lesions, may simulate invasive carcinoma. Fibrosis, inflammatory reaction, and other stromal changes around in situ carcinoma may mask microinvasive foci on routine stains. Conventional immunohistochemistry to demonstrate basement membrane or myoepithelial cell layer may not, by itself, be unequivocally diagnostic of invasion. We performed a novel double immunoenzyme labeling technique using an avidin-biotin complex peroxidase-diaminobenzidine system for smooth-muscle actin followed by an alkaline phosphatase anti-alkaline phosphatase-new fuchsin system for cytokeratin antigen on formalin-fixed, paraffin-embedded histology sections to evaluate 32 such problematic cases. The initial histologic impression with hematoxylin and eosin staining alone was as follows-first group: microinvasive carcinoma-10; second group: carcinoma in situ--"stromal invasion cannot be ruled out"--15; third group: frankly infiltrating carcinoma of various grades and morphologic types-6. The last group served as positive control for invasion. One fibroadenoma with fine-needle-aspiration-induced artifact simulating stromal invasion was also included. The double immunoenzyme labeling technique imparted a dark brown color to the myoepithelial cells and a vivid red color to the epithelial cells, making individual or loosely cohesive groups of malignant epithelial cells infiltrating the stroma easily detectable, whereas their in situ counterparts were contained within dark brown myoepithelial boundaries. The TNM 1997 definition of pT1mic, i.e., extension of malignant cells in the stroma with no focus measuring >0.1 cm, was followed to classify microinvasion. In the first group, microinvasion was confirmed in six cases but was not demonstrable in four. In the second group, definite invasion was identified in five cases, ruled out in nine, and in one case the suspicion of early invasion could not be entirely ruled out even after double immunoenzyme labeling. Thus, it was possible to render a definite opinion regarding presence or absence of invasion in 24 of 25 (96%) cases diagnosed as or suspected to be microinvasive. The precise and simultaneous elucidation of topography between malignant cells and myoepithelial cells on a single permanent section makes this technique a useful diagnostic tool in the evaluation of those cases of breast carcinoma that exhibit equivocal invasion.
Subject(s)
Actins/analysis , Breast Neoplasms/pathology , Carcinoma/pathology , Keratins/analysis , Breast Neoplasms/chemistry , Carcinoma/chemistry , Carcinoma in Situ/chemistry , Carcinoma in Situ/pathology , Carcinoma, Ductal, Breast/chemistry , Carcinoma, Ductal, Breast/pathology , Carcinoma, Lobular/chemistry , Carcinoma, Lobular/pathology , Female , Fibroadenoma/chemistry , Fibroadenoma/pathology , Fibrocystic Breast Disease/chemistry , Fibrocystic Breast Disease/pathology , Humans , Immunoenzyme Techniques , Neoplasm Invasiveness , Sclerosis/pathologyABSTRACT
Kaposi's sarcoma-associated herpesvirus (KSHV), or human herpesvirus 8, is invariably present in Kaposi's sarcoma lesions. KSHV contains several viral oncogenes and serological evidence suggests that KSHV infection is necessary for the development of Kaposi's sarcoma, but cellular transformation by this virus has not so far been demonstrated. KSHV is found in the microvascular endothelial cells in Kaposi's sarcoma lesions and in the spindle 'tumour' cells, which are also thought to be of endothelial origin. Here we investigate the biological consequences of infecting human primary endothelial cells with purified KSHV particles. We find that infection causes long-term proliferation and survival of these cells, which are associated with the acquisition of telomerase activity and anchorage-independent growth. KSHV was present in only a subset of cells, and paracrine mechanisms were found to be responsible for the survival of uninfected cells. Their survival may have been mediated by upregulation of a receptor for vascular endothelial growth factor. Our results indicate that transformation of endothelial cells by KSHV, as well as paracrine mechanisms that are induced by this virus, may be critical in the pathogenesis of Kaposi's sarcoma.
Subject(s)
Cell Transformation, Neoplastic , Cell Transformation, Viral , Endothelium, Vascular/virology , Herpesvirus 8, Human/physiology , Sarcoma, Kaposi/virology , Antigens, Viral/biosynthesis , Cell Adhesion , Cell Division , Cell Survival , Cells, Cultured , DNA, Viral/analysis , Endothelial Growth Factors/physiology , Endothelium, Vascular/pathology , Humans , Lymphokines/physiology , Receptor Protein-Tyrosine Kinases/metabolism , Receptors, Growth Factor/metabolism , Receptors, Vascular Endothelial Growth Factor , Telomerase/metabolism , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors , Virus ReplicationABSTRACT
Primary effusion (body cavity-based) lymphoma (PEL) is a recently recognized subtype of malignant lymphoma that exhibits distinctive clinical and biological features, most notably its usual infection with the Kaposi's sarcoma-associated herpesvirus (KSHV). The vast majority of cases also contain Epstein-Barr virus (EBV). This dual viral infection is the first example of a consistent dual herpesviral infection in a human neoplasm and provides a unique model to study viral interactions. We analyzed the pattern of EBV latent gene expression to determine the pathogenic role of this agent in PELs. We examined five PELs coinfected with EBV and KSHV by reverse transcription-polymerase chain reaction (RT-PCR), in situ hybridization, and immunohistochemistry. EBER1 mRNA, a consistent marker of viral latency, was positive in all PEL cases, although at lower levels than in the non-PEL controls due to EBER1 expression by only a variable subset of lymphoma cells. Qp-initiated mRNA, encoding only EBNA1 and characteristic of latencies I and II, was positive in all PEL cases. Wp- and Cp-initiated mRNAs, encoding all EBNAs and characteristic of latency III, were negative in all cases. LMP1 mRNA, expressed in latencies II and III, was present in three cases of PEL, although at very low levels that were not detectable at the protein level by immunohistochemistry. Low levels of LMP2A mRNA were detected in all cases. BZLF1, an early-intermediate lytic phase marker, was weakly positive in four cases, suggesting a productive viral infection in a very small proportion of cells, which was confirmed by ZEBRA antigen expression. Therefore, PELs exhibit a restricted latency pattern, with expression of EBNA1 in all cases, and low LMP1 and LMP2A levels.
Subject(s)
DNA-Binding Proteins/biosynthesis , Epstein-Barr Virus Nuclear Antigens/biosynthesis , Gene Expression Regulation, Neoplastic , Gene Expression Regulation, Viral , Herpesviridae Infections/virology , Herpesvirus 4, Human/isolation & purification , Herpesvirus 8, Human/isolation & purification , Lymphoma, Non-Hodgkin/virology , Trans-Activators/biosynthesis , Tumor Virus Infections/virology , Viral Matrix Proteins/biosynthesis , Viral Proteins , Adult , Aged , DNA-Binding Proteins/genetics , Epstein-Barr Virus Nuclear Antigens/genetics , Herpesviridae Infections/metabolism , Herpesvirus 4, Human/genetics , Herpesvirus 4, Human/pathogenicity , Herpesvirus 4, Human/physiology , Herpesvirus 8, Human/pathogenicity , Humans , In Situ Hybridization , Lymphoma, AIDS-Related/metabolism , Lymphoma, AIDS-Related/virology , Lymphoma, Non-Hodgkin/metabolism , Male , Polymerase Chain Reaction , RNA Splicing , RNA, Messenger/analysis , RNA, Neoplasm/analysis , RNA, Viral/analysis , Trans-Activators/genetics , Tumor Cells, Cultured , Tumor Virus Infections/metabolism , Viral Matrix Proteins/genetics , Virus LatencyABSTRACT
The early development of symptoms and the rapid progression of disease in some vertically infected infants are thought to reflect in part the immaturity of their immune systems. We examined the relationship between HIV-specific CTL activity and the profile of cytokine production induced by mAb to CD3 and HIV envelope (env) peptides P18 and T1 in PBMC derived from 0.6- to 3.6-yr-old children with perinatal HIV infection. Cellular immunity against HIV was demonstrated only during early stages of disease, whereas the responses were either undetectable or at background levels in HIV-infected children with rapidly progressing disease and in uninfected children of HIV+ and HIV- mothers. Levels of IL-2 mRNA in anti-CD3 mAb- and env peptide-induced PBMC varied and were increased in the infected children with high frequencies of HIV-specific CTL precursors. Analysis of IFN-gamma and IL-4 production by CD4+ T cell clones obtained from cultures stimulated with anti-CD3 mAb or the env peptides showed an increased proportion of Th2 and Th0 clones in HIV-infected children with lower HIV-specific CTL activity, whereas children with high CTL activity had increased numbers of Th1 clones. The results of these studies suggest that decreases in CTL activity to the virus might be associated with the induction of a type 2 cytokine response. These findings underline the role of cytokines in the generation of HIV-specific CTL responses and may be important for the development of immunomodulatory and vaccine strategies to interrupt vertical transmission of HIV.
Subject(s)
HIV Infections/immunology , T-Lymphocytes, Cytotoxic/immunology , Antibodies, Monoclonal/immunology , CD3 Complex/analysis , CD3 Complex/immunology , Cells, Cultured , Child, Preschool , Humans , Infant , Infectious Disease Transmission, Vertical , Interferon-gamma/biosynthesis , Interleukin-2/analysis , Interleukin-4/biosynthesis , Leukocytes, Mononuclear/immunology , Peptides/immunology , RNA, Messenger/analysis , Th2 Cells/immunology , Viral Envelope Proteins/immunologyABSTRACT
Progression of HIV-induced immunodeficiency is associated with both B cell activation and an increased proportion of Vdelta1+ T cells in PBL. To examine whether the peripheral expansion of Vdelta1+ cells is driven by activated B cells, we isolated CD19+ PBL from HIV+ individuals at different stages of infection and used them to stimulate Vdelta1+ T cell clones. The Vdelta1+ T cell clones were isolated from HIV+ individuals and selected on the basis of cytotoxic activity and IFN-gamma expression in response to lymphoblastoid cell lines (LCLs) established from patients with AIDS (AIDS-related LCLs) but not LCLs of HIV- donors. Peripheral blood B cells from HIV+ patients induced IFN-gamma expression in these Vdelta1+ clones, and their stimulatory ability was associated with up-regulated expression of the CD38 activation Ag and with a 6- to 10-fold increased spontaneous Ig production. Stimulation of CD19+ PBL from HIV+ individuals with cross-linked anti-CD40 mAb or rgpl20 further augmented induction of IFN-gamma expression in the Vdelta1+ cells. The isolated Vdelta1+ T cell clones expressed the Jdelta1 gene segment, but differed in Vgamma gene segment usage and in the junctional region of TCR-delta chains, indicating Vdelta gene-determined recognition. These results provide evidence that the peripheral expansion of Vdelta1+ cells in HIV infection is associated with phenotypic and functional alterations of B cells, due to chronic activation during progression to AIDS.
Subject(s)
B-Lymphocytes/physiology , HIV Infections/immunology , Lymphocyte Activation , Receptors, Antigen, T-Cell, gamma-delta/analysis , T-Lymphocyte Subsets/immunology , ADP-ribosyl Cyclase , ADP-ribosyl Cyclase 1 , Acquired Immunodeficiency Syndrome/immunology , Adult , Amino Acid Sequence , Antigens, CD/analysis , Antigens, Differentiation/analysis , Base Sequence/genetics , Clone Cells , Disease Progression , HIV Infections/etiology , Humans , Interferon-gamma/biosynthesis , Membrane Glycoproteins , Molecular Sequence Data , N-Glycosyl Hydrolases/analysisABSTRACT
Five cases of clinically aggressive, keratin-positive malignant lymphomas of B-cell type with unusual immunophenotypes were studied. All cases were extranodal: two from the stomach, one from soft tissue, one from the skin, and one from the spleen. These tumors were undifferentiated large-cell neoplasms that showed reactivity for low-molecular-weight keratin 8, but they were negative for keratin 19; three cases were also positive for epithelial membrane antigen. The immunohistochemical diagnosis was complicated by the fact that two of these cases lacked reactivity for leukocyte common antigen and three were CD20 negative. These findings simulated the immunophenotype of a carcinoma and led to an initial misdiagnosis of carcinoma. Although only two cases showed immunohistochemical evidence of B-cell lineage (CD20+), all five cases were documented as B-cell lymphomas on the basis of the clonal immunoglobulin heavychain gene rearrangement, as demonstrated by polymerase chain reaction (PCR) in all the cases and by Southern blot hybridization in three cases; all cases were negative for T-cell markers, and three cases showed germline configuration for T-cell receptor beta-chain. One case was strongly CD30 positive and represented large-cell anaplastic lymphoma of B-cell type. Our results show that some B-cell lymphomas can have unusual and confusing immunophenotypes, including keratin positivity and leukocyte antigen negativity. Use of PCR-based molecular genetic demonstration of clonal immunoglobulin heavychain gene rearrangement is helpful in establishing the correct diagnosis in such cases.
Subject(s)
Keratins/metabolism , Lymphoma, B-Cell/metabolism , Lymphoma, Large B-Cell, Diffuse/metabolism , Lymphoma, Non-Hodgkin/metabolism , Aged , Female , Gene Rearrangement , Humans , Immunoglobulin Heavy Chains/genetics , Immunohistochemistry , Lymphoma, B-Cell/genetics , Lymphoma, B-Cell/pathology , Lymphoma, Large B-Cell, Diffuse/genetics , Lymphoma, Large B-Cell, Diffuse/pathology , Lymphoma, Non-Hodgkin/genetics , Lymphoma, Non-Hodgkin/pathology , Male , Middle Aged , Molecular Biology , Phenotype , Polymerase Chain ReactionABSTRACT
Patterns of cytokine expression were analyzed in polyclonal and antigenic responses in children with perinatal HIV infection. Responses of PBL to PMA and A23187 calcium ionophore studied in patients in different stages of HIV infection revealed reduced levels of IL-2 in HIV-infected children beginning before 6 mo of age, and age-dependent increases in expression of IL-4, IL-10, and IFN-gamma. The levels of IL-4, IL-10, and IFN-gamma expression did not differ significantly between HIV-infected and age-matched uninfected children of HIV-seropositive mothers, except for a small reduction in HIV-infected children in late stages of infection. Responses to PHA, HLA alloantigens, HIV envelope peptides T1 and P18, and tetanus toxoid were studied in PBMC derived from asymptomatic and mildly symptomatic HIV-infected children. IL-2, IFN-gamma, IL-4, and IL-5 expression was detected in PHA-stimulated PBMC from all analyzed patients. HIV-infected children who failed to respond to HLA alloantigens, tetanus toxoid, or the envelope peptides had lower numbers of CD4+ cells and expressed, on PHA stimulation, higher levels of IL-4 and IL-5 and lower levels of IL-2 and IFN-gamma than patients who responded to the antigenic stimulation. Results of these analyses suggest that cytokine expression in HIV-infected children depends on the character of the stimuli as well as the phenotype of PBMC, and indicate possible prevalence of Th2 Ag-specific responses during the progression of HIV-induced immunodeficiency.
Subject(s)
Acquired Immunodeficiency Syndrome/immunology , Cytokines/metabolism , HIV Infections/immunology , Pregnancy Complications, Infectious/immunology , Th1 Cells/metabolism , Th2 Cells/metabolism , Acquired Immunodeficiency Syndrome/drug therapy , Acquired Immunodeficiency Syndrome/etiology , Cytokines/analysis , Disease Progression , Female , Humans , Infant , Infant, Newborn , Ionomycin/pharmacology , Lymphocyte Activation , Pregnancy , Prospective Studies , RNA, Messenger/analysis , Tetradecanoylphorbol Acetate/pharmacologyABSTRACT
To study the mechanism by which sulfated polysaccharides with 1,3-beta-D-glucan as a main chain exert anti-HIV-1 activity, we analyzed the effects of curdlan sulfate (CRDS) on HIV-1 infection of SupT-1 cells and peripheral blood mononuclear cells. CRDS had no effect on virions inhibited weakly HIV-1 attachment to cells, and had to be present for 24 hr to achieve protection. Lack of HIV-1 DNA corresponding to the gag region in cells incubated with the virus and CRDS and inhibition of infection after addition of 2',3'-dideoxyinosine to cells treated with CRDS and HIV-1 for less than 24 hr suggest that CRDS delays events that precede and/or include reverse transcription. Analysis of the effect of CRDS on binding of HIV-1 neutralizing antibodies to gp 120 demonstrated that both the continuous epitopes on the V3 loop and the discontinuous CD4 binding site of gp 120 represent targets for CDRS. This interaction of CRDS with functional gp 120 domains suggests that CRDS interferes with the membrane fusion process during HIV-1 infection. Concentrations of CRDS that were protective against infection with T cell- and macrophage-tropic HIV-1 isolates had less suppressive effects on T cell function in comparison with the related compound, dextran sulfate.
Subject(s)
Antiviral Agents , CD4-Positive T-Lymphocytes/microbiology , Glucans/pharmacology , HIV-1/drug effects , Virus Replication/drug effects , beta-Glucans , Anions , Base Sequence , Cell Fusion/drug effects , Circular Dichroism , Cytotoxicity, Immunologic/drug effects , DNA Primers/chemistry , HIV Envelope Protein gp120/chemistry , HIV Envelope Protein gp120/metabolism , In Vitro Techniques , Interleukin-2/biosynthesis , Molecular Sequence Data , Polyelectrolytes , Polymers , T-Lymphocytes, Cytotoxic/drug effects , Virion/metabolismABSTRACT
gamma delta T cells bearing the V gamma 9 gene segment have been shown to recognize staphylococcal enterotoxin A (SEA) and a range of other Ags including mycobacterial Ags. We have established an experimental system to analyze the recognition properties of human TCR-gamma delta on a molecular level by transferring the receptor from its original T cell into a Jurkat T cell host that does not express an endogenous TCR. Three groups of transfectants that express the same delta-chain, V delta 1, but different gamma-chains (V gamma 9-J2-C gamma 2, V gamma 3-J2-C gamma 2, and V gamma 9-JP-C gamma 1) together with the endogenous CD3 were obtained. The transfectant T cells each expressing different gamma delta receptors all produced IL-2 after stimulation with plastic bound anti-CD3 Ab, but only those expressing V gamma 9 responded to stimulation with SEA in the presence of an autologous lymphoblastoid B cell line. In addition, transfectants that expressed V delta 2 combined with V gamma 9 could also respond to SEA. These results indicate that the V gamma 9 portion of the receptor, independent of the J region and C region or the delta-chain, is responsible for recognizing SEA.
Subject(s)
Enterotoxins/immunology , Receptors, Antigen, T-Cell, gamma-delta/immunology , Amino Acid Sequence , Base Sequence , CD3 Complex/physiology , Cell Line , DNA Primers/chemistry , Gene Transfer Techniques , Humans , Interleukin-2/biosynthesis , Lymphocyte Activation , Molecular Sequence Data , Receptors, Antigen, T-Cell, gamma-delta/genetics , Structure-Activity RelationshipABSTRACT
The present study examined CD8 antigen expression and variable (V) gene segment usage by T cell receptor (TCR)-gamma delta+ lymphocytes in peripheral blood of symptomatic children with perinatal HIV infection. The relative number of gamma delta+, CD8+ T cells in most of the infected children was higher than that in uninfected children from HIV+ or HIV- mothers and correlated with the immunodeficiency status of the patients. Infected infants and children over 1 year old also showed an increased proportion of V delta 1-J delta 1+ T lymphocytes. CD8 expression on those cells was higher in infected than in uninfected infants and children. Sequence analysis of the delta gene rearrangement of the predominant V delta 1 family in peripheral blood of three HIV+ donors revealed extensive junctional diversity. These results suggest that the V delta skewing in the majority of HIV+ children reflects peripheral expansion of V delta 1-J delta 1+ T lymphocytes early in life, which might be involved in the mechanisms of HIV-induced immunodeficiency.
Subject(s)
HIV Infections/immunology , Receptors, Antigen, T-Cell, gamma-delta/analysis , T-Lymphocytes/immunology , Base Sequence , CD3 Complex/immunology , CD4-CD8 Ratio , Child , Child, Preschool , Flow Cytometry , Gene Rearrangement, delta-Chain T-Cell Antigen Receptor/genetics , HIV Seropositivity/immunology , Humans , Infant , Infant, Newborn , Molecular Sequence Data , Polymerase Chain Reaction , Receptors, Antigen, T-Cell, gamma-delta/genetics , T-Lymphocytes, Regulatory/immunologyABSTRACT
Synthetic RNAs (sRNAs) specific for four human cytokines were constructed and used as an exogenous internal standard in a quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). The sequences of the sRNA and the target mRNA were identical except for a duplication or deletion of approximately 100 nucleotides. The size difference between these two templates permitted easy electrophoretic separation of their PCR products. The sRNA has polyadenylated sequences at the 3' end and can be added directly either to a cell lysate before RNA purification or to a reverse transcription reaction. One pair of primers is used to amplify the internal standard and the target simultaneously, and the ratio of the two PCR products remains constant throughout the amplification. This technique can be applied to quantitate specific mRNA in as few as 10 cells when the exogenous control is added directly to cell lysates. This method is sensitive, accurate and adaptable for quantitation of other transcripts.
Subject(s)
Cytokines/biosynthesis , Leukocytes/metabolism , RNA, Messenger/biosynthesis , Blotting, Northern , Cell Extracts/chemistry , Cells, Cultured , Cytokines/genetics , Enzyme-Linked Immunosorbent Assay , Humans , Polymerase Chain Reaction/methods , RNA/chemical synthesis , RNA Probes , RNA-Directed DNA Polymerase , Sensitivity and Specificity , Transcription, GeneticABSTRACT
The characteristic features are presented of intermediate lymphocytic lymphomas which have suggested the pathomorphological and clinical peculiarity of this disease entity. They occur in two forms: diffuse and nodular which are two phases in the development of the disease. The phenotypic and karyotypic characteristics of these lymphomas resemble those of chronic lymphocytic leukaemia, but their more malignant course is similar to that of centrocytic lymphomas.
Subject(s)
Lymphoma, Non-Hodgkin/pathology , Humans , Karyotyping , Lymphoma, Non-Hodgkin/genetics , PhenotypeABSTRACT
Several problems concerning the etiology and pathogenesis of malignant granulomatosis have been presented with particular attention paid to immune disturbances in the course of this disease. Some modern theories of the origin of Reed-Sternberg neoplastic cells have been also discussed.